Kokilaben Dhirubhai Ambani Hospital Mumbai enhances cancer treatment precision with Next-Gen Radiation Technology

Kokilaben Dhirubhai Ambani Hospital Mumbai enhances cancer treatment precision with Next-Gen Radiation Technology

~ Adopting the Radixact® system, the Hospital sets a global benchmark in cancer care, transforming the patient experience ~

Mumbai, July 1, 2025: Kokilaben Dhirubhai Ambani Hospital Mumbai is proud to announce a significant advancement in its cancer treatment capabilities with the upgrade of its radiation therapy, with the state-of-the-art Radixact® Treatment Delivery System. This cutting-edge technology strengthens the hospital’s leadership in oncology by improving patient outcomes through enhanced precision, safety, and adaptability in cancer treatment.

The addition of Radixact® strengthens Kokilaben Hospital’s comprehensive cancer care offering, bringing together a powerful combination of next-gen infrastructure, organ‑wise sub‑specialty expertise and globally benchmarked protocols, all under one roof.

The Radixact® system is a significant advancement in radiation therapy, offering precise treatment that minimizes exposure to healthy tissues. Equipped with a built-in CT scanner, it provides real-time imaging to ensure the tumor is in the correct position throughout treatment. The system is versatile, capable of treating various types of cancer across different areas of the body. By safely delivering higher doses of radiation, Radixact enhances treatment effectiveness. Its Synchrony technology adapts to body movements, maintaining accuracy even during breathing. This approach ensures a safer and more effective treatment experience for patients.

Complementing Radixact®, Kokilaben Hospital has one of India’s largest assemblies of precision oncology technologies. It is backed by a team of over 300 highly experienced and world-renowned multidisciplinary cancer specialists. The hospital is also at the forefront of genomic oncology, with a state-of-the-art Molecular and Genomics Laboratory that offers a 500-gene somatic cancer panel, enabling highly personalised treatment protocols. This data-driven approach supports advanced diagnosis, targeted therapies, and improved clinical outcomes. The integrated ecosystem ensures that every patient benefits from advanced technology, sub-specialty expertise, and data-driven, individualised care.

Further, The Radixact system allows for more accurate tumour targeting with its ability to adapt to changes in patient anatomy or tumor movement during treatment, even accounting for breathing. These advanced features supports clinicians in providing optimal, personalized care with greater precision and efficiency.

Dr Santosh Shetty, Executive Director and CEO of Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute said,  “At Kokilaben Hospital, we are constantly pushing the boundaries of medical innovation to ensure our patients receive the most advanced and effective treatment. The adoption of the globally acclaimed Radixact® system marks a major leap forward in our commitment to delivering world-class cancer care. As a centre that continues to be recognized for its leadership in oncology, we are proud to bring one of the most sophisticated radiation technologies to India. This upgrade reaffirms our dedication to adopting global standards that improve both clinical outcomes and quality of care.”

With the rising cancer burden in India, the integration of the Radixact® system is more than a technological upgrade, it represents a shift toward the future of cancer care in India not only elevating the standard of treatment but also transforming patients’ lives. As one of India’s foremost cancer care institutions, Kokilaben Dhirubhai Ambani Hospital continues to lead the way in delivering cutting-edge, patient-centric oncology solutions.ends GNI